VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Merck & Co., Inc. vs Nasdaq, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Merck & Co., Inc.
MRK · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.
View MRK analysisNasdaq, Inc.
NDAQ · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Nasdaq, Inc.'s moat claims, evidence, and risks.
View NDAQ analysisComparison highlights
- Moat score gap: Nasdaq, Inc. leads (76 / 100 vs 71 / 100 for Merck & Co., Inc.).
- Segment focus: Merck & Co., Inc. has 2 segments (89.5% in Pharmaceutical); Nasdaq, Inc. has 3 segments (42.4% in Capital Access Platforms).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Merck & Co., Inc. has 5 moat types across 3 domains; Nasdaq, Inc. has 9 across 5.
Primary market context
Merck & Co., Inc.
Pharmaceutical
Branded prescription pharmaceuticals & human vaccines
Global
Wholesalers/retailers, managed care and government payers, hospitals/clinics
R&D-intensive innovator, manufacturer, and marketer
89.5%
Nasdaq, Inc.
Capital Access Platforms
Issuer and investor solutions: listings, index licensing, market data, and investment analytics/workflow platforms
Global (with major exposure to U.S. and Nordic/Baltic markets)
Public/private companies (issuers), asset managers, institutional investors, data subscribers
Listing venue + index administrator/licensor + data/analytics provider
42.4%
Side-by-side metrics
Moat coverage
Shared moat types
Merck & Co., Inc. strengths
Nasdaq, Inc. strengths
Segment mix
Merck & Co., Inc. segments
Full profile >Pharmaceutical
Competitive
Animal Health
Oligopoly
Nasdaq, Inc. segments
Full profile >Market Services
Competitive
Capital Access Platforms
Oligopoly
Financial Technology
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.